Komori
Cyberdyne (7779) · RiskMitigated

Impact of COVID-19 on Business Activities

First written in FY2020. 7 of 10 entries say "Materialised", first in FY2020. Latest entry: FY2024-Q1.

10entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2020 – FY2022-Q3MitigatedFY2023-Q1 – FY2024-Q12020: 320202021: 320212022: 220222023: 22023
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1327 companies write about · 1339 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1352 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1MitigatedAnnual report

    「The introduction of medical-use HAL® at medical institutions was temporarily delayed due to COVID-19, but orders have been recovering since the start of the new fiscal year in April 2023 as the pandemic subsided.」

    Regarding delays in the introduction of products for medical institutions due to COVID-19, it states that orders have been recovering as the pandemic subsided.
  2. FY2023-Q3MitigatedAnnual report

    「The future spread of COVID-19 is difficult to predict with a certain degree of certainty, but we have prepared accounting estimates based on the assumption that conditions will gradually recover toward the middle of the next consolidated fiscal year. As of the end of the third quarter of the consolidated accounting period under review, we determined that the impact of the accounting estimate-related assumption and changes in it on our group was not material, because even if the assumption changed within a reasonable range, the impact on the conclusion based on the evaluation results would be limited.」

    Regarding the impact of COVID-19, we have assumed a recovery toward the middle of the next consolidated fiscal year and determined that the accounting impact of changes in the assumption would not be material.
  3. FY2023-Q1MitigatedAnnual report

    「As of the end of the first quarter of the consolidated accounting period under review, we determined that the impact of the accounting estimate-related assumption and changes in it on our group was not material, because even if the assumption changed within a reasonable range, the impact on the conclusion based on the evaluation results would be limited.」

    We have assumed that the effects of COVID-19 will gradually recover toward the end of the fiscal year. We have determined that the impact of changes in the assumption underlying the accounting estimates is limited and not material.
  4. FY2022-Q3MaterialisedAnnual report

    「During the consolidated accounting period under review through the third quarter, the short-term impact on sales has continued, due to the temporary suspension of the RoboCare business in the first half and the treatment services business in Germany, temporary delays in new business negotiations, contracts and shipments, particularly to medical institutions, and a decline in rentals of the HAL® lower-back type for work assistance at airports.」

    The impact of the suspension of the RoboCare business and treatment services in Germany due to COVID-19, delays in business negotiations and other activities with medical institutions, and a decline in airport rentals has continued.
  5. FY2022-Q2MaterialisedAnnual report

    「During the second quarter of the consolidated accounting period under review, the RoboCare business in Japan and the treatment services business in Germany were recovering, but the impact on short-term sales continued due to temporary delays in new business negotiations, contracts and shipments in Japan and overseas, particularly to overseas medical institutions.」

    The RoboCare business in Japan and treatment services in Germany were recovering, while delays in business negotiations, contracts and shipments, particularly involving overseas medical institutions, and their impact on short-term sales continued.
  6. FY2022-Q1MaterialisedAnnual report

    「During the first quarter of the consolidated accounting period under review, the RoboCare business in Japan and the treatment services business in Germany were recovering, but the impact on short-term sales continued due to temporary delays in new business negotiations, contracts and shipments in Japan and overseas, particularly to medical institutions.」

    The RoboCare business and treatment services in Germany were recovering, while delays in business negotiations, contracts and shipments, primarily involving medical institutions, and their impact on short-term sales continued to occur.
  7. FY2021-Q3MaterialisedAnnual report

    「During the consolidated accounting period under review through the third quarter, the short-term impact on sales has continued, due to the temporary suspension of the RoboCare business in the first half and the treatment services business in Germany, temporary delays in new business negotiations, contracts and shipments, particularly to medical institutions, and a decline in rentals of the HAL® lower-back type for work assistance at airports.」

    The impact of the suspension of the RoboCare business and treatment services in Germany due to COVID-19, delays in business negotiations and other activities with medical institutions, and a decline in airport rentals on short-term sales has continued.
  8. FY2021-Q2MaterialisedAnnual report

    「In the current second-quarter consolidated accounting period, temporary short-term sales impacts occurred due to the temporary suspension of the RoboCare business and the treatment services business in Germany, temporary delays in new business discussions, contracts and shipments, particularly for medical institutions, and a decline in rentals of HAL® Lower Limb Type for Work Assistance for airports.」

    The impact of COVID-19 has continued to result in the suspension of the RoboCare business and treatment services in Germany, delays in business discussions and other activities for medical institutions, a decline in rentals for airports, and an impact on short-term sales.
  9. FY2021-Q1MaterialisedAnnual report

    「In the current first-quarter consolidated accounting period, temporary short-term sales impacts occurred due to the temporary suspension of the RoboCare business and the treatment services business in Germany, as well as temporary delays in new business discussions, contracts and shipments, particularly for medical institutions.」

    The impact of COVID-19 actually resulted in the temporary suspension of the RoboCare business and treatment services in Germany, delays in new business discussions, contracts and shipments, and an impact on short-term sales.
  10. FY2020MaterialisedAnnual report

    「Regarding the impact of the spread of COVID-19, the assumptions used by the Company in making accounting estimates are based on the expectation that, as the spread of the infection subsides and economic activity resumes in each region, conditions will gradually recover toward the end of the following consolidated fiscal year.」

    The spread of COVID-19 has actually affected people’s behavior, local operations, shipments and accounting estimates, and the Company has described its responses, including teleworking, web conferencing and social distancing.
Moved together

"Persistent losses due to front-loaded research and development spending" moved the same way as this thread, in the same document, in 6 of its 10 moves.

655333★123456
  1. ★This thread
  2. 1Persistent losses due to front-loaded research and development spending6×
  3. 2Operating cash flow turns positive5×
  4. 3Risk of Eliminating Negative Retained Earnings and Tax Loss Carryforwards5×
  5. 4International expansion and market development in the human support industry3×
  6. 5Coverage under healthcare and long-term care insurance in major EU countries3×
  7. 6Domestic and international clinical trials to expand the indications3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Cyberdyne yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.